Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 281Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Polfa Tarchomin

02 1Hiral Labs

03 2Titan Laboratories Pvt Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Regulatory Info : Dossier Availability: Q3 2025

Registration Country : Poland

Lymecycline

Brand Name :

Dosage Form : Hard Capsule

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Availability: Q3 2025

Registration Country : Poland

Polfa Tarchomin

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Packaging :

Regulatory Info : Dossier Availability: Q3 2025

Lymecycline

Dosage : Hard Capsule

Dosage Strength : 150MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Poland

Polfa Tarchomin

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Regulatory Info : Dossier Availability: Q3 2025

Registration Country : Poland

Lymecycline

Brand Name :

Dosage Form : Hard Capsule

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Availability: Q3 2025

Registration Country : Poland

Polfa Tarchomin

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Packaging :

Regulatory Info : Dossier Availability: Q3 2025

Lymecycline

Dosage : Hard Capsule

Dosage Strength : 300MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Poland

Polfa Tarchomin

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Lymecycline

Brand Name :

Dosage Form : Capsule

Dosage Strength : 408mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Lymecycline

Dosage : Capsule

Dosage Strength : 408mg

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Lymecycline

Brand Name :

Dosage Form : Capsule

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

04

2024 ACI Convention
Not Confirmed
arrow

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Lymecycline

Brand Name :

Dosage Form : Capsule

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

05

2024 ACI Convention
Not Confirmed
arrow